References
- Vollmer R R. Effects of dietary sodium on sympathetic nervous system control of cardiovascular function. J Auton Pharmac 1984; 4: 133–144
- McNeill J R. Role of vasopressin in the control of arterial pressure. Can J Physiol Pharmacol 1983; 61: 1226–1235
- Liard J F. Vasopressin in cardiovascular control: role of circulating vasopressin. Clin Sci 1984; 67: 473–481
- Share L, Crofton J T. The role of vasopressin in hypertension. Federation Proc 1984; 43: 103–106
- deChamplain J, van Ameringen M R. Regulation of blood pressure by sympathetic nerve fibers and adrenal medulla in normotensive and hypertensive rats. Circ Res 1972; 31: 617–628
- Takeda K, Buñag R D. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats. Hypertension 1980; 2: 97–101
- Reid J L, Zivin J A, Kopin I J. Central and peripheral adrenergic mechanisms in the development of Deoxycorticosterone-saline hypertension in rats. Circ Res 1975; 37: 569–579
- Rascher W, Dietz R, Schömig A, Weber J, Gross F. Plasma catecholamine levels and vascular response in deoxycorticosterone acetate hypertension of rats. Clin Sci 1980; 59: 315s–317s
- Möhring J, Möhring B, Petri M, Haack D. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol 1977; 232: F260–F269
- Crofton J T, Share L, Shade R E, Lee-Kwon W J, Manning M, Sawyer W H. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension 1979; 1: 31–38
- Crofton J T, Share L, Wang B C, Shade R E. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension 1980; 2: 4224–431
- Yamamoto J, Yamane Y, Umeda Y, Yoshioka T, Nakai M, Ikeda M. Cardiovascular hemodynamics and vasopressin blockade in DOCA-salt hypertensive rats. Hypertension 1984; 6: 397–407
- Mento P F, Wang H, Sawyer W H. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats. Proc Soc Exp Biol Med 1984; 175: 58–63
- Hofbauer K G, Mah S C, Baum H P, Hänni H, Wood J M, Kraetz J. Endocrine control of salt and water excretion: The role of vasopressin in DOCA-salt hypertension. J Cardiovasc Pharmacol 1984; 6: s184–s191
- Hofbauer K G, Studer W, Mah S C, Michel J B, Wood J M, Stalder R. The significance of vasopressin as a pressor agent. J Cardiovasc Pharmacol 1984; 6: s429–s438
- Berecek K H, Murray R D, Gross F, Brody M J. Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension 1982; 4: 3–12
- Morrison D F. Multivariate Statistical Methods, Second Edition. McGraw-Hill International Book Company. 1983
- Rabito S F, Carretero O A, Scicli A G. Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension. Hypertension 1981; 3: 34–38
- Rascher W, Lang R E, Taubitz M, Meffle H, Unger T H, Ganten D, Gross F. Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex. Cli Sci 1981; 61: 153s–156s
- Bonjour J P, Malvin R L. Plasma concentrations of ADH in conscious and anesthetized dogs. Am J Physiol 1970; 218: 1128–1132
- Saito T, Yajima Y, Watanabe T. Involvement of AVP in the development and maintenance of hypertension in rats. Antidiuretic hormone, S Yoshida, I Share, K Yagi. Japan Sci Soc Press, Tokyo 1980
- Andrews C E, Brenner B M. Relative contribution of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water deprived rat. Circ Res 1981; 48: 254–258